Clinical trial for people with early-stage Parkinson’s disease

Nuvance Health is enrolling patients in a clinical trial to evaluate the safety and efficacy of the investigational drug UCB0599 to slow disease progression in individuals with early-stage Parkinson’s disease (PD). At this time, Nuvance Health is the only site in Connecticut conducting the clinical trial.

The Orchestra clinical trial (oral new chemical entity aiming to slow disease trajectory) is an 18-month study.

“Approximately 60 thousand people are diagnosed with Parkinson’s disease each year in the United States and 10 million people are living with it worldwide. Finding new ways to treat Parkinson’s disease is important, and clinical studies play an integral part in helping advance our understanding of the disease and how to treat it,” said Dr. Robert Bonwetsch, board-certified neurologist and Principal Investigator.

PD — the second most common neurodegenerative disease after Alzheimer’s disease — is a progressive movement disorder. Symptoms include trembling of hands, arms, legs, jaw and face and poor balance and coordination. As symptoms worsen, individuals may have difficulty chewing, swallowing or speaking, talking or walking.

Individuals diagnosed with PD within the last two years in overall good health who have not received medication for PD-associated motor symptoms may be eligible for the Orchestra study.

Individuals who think they may be eligible or physicians referring their patients to the clinical trial can call (203) 739-4551 or email OfficeofClinicalTrials@NuvanceHealth.org.

The clinical trial site is located at Associated Neurologists, P.C, 69 Sand Pit Road, Suite 300, Danbury, Connecticut.

Clinical trial participants will have access to an investigational drug that is studying PD symptoms progression. Participants will also have access to care and support services for movement disorders at Nuvance Health.

CONTACT

Amy Forni, Manager, Public Relations
O: (203) 739-7478 | M: (475) 279-4673 | Amy.Forni@nuvancehealth.org

About Nuvance Health

Nuvance Health is a family of award-winning nonprofit hospitals and healthcare professionals in the Hudson Valley and western Connecticut. Nuvance Health combines highly skilled physicians, advanced facilities and technology and compassionate caregivers dedicated to providing quality care across a variety of services including the Cancer Institute, Heart and Vascular Institute, Neuroscience Institute and orthopedics, primary care and surgery.

Nuvance Health has convenient hospitals and outpatient locations including Danbury Hospital and its New Milford campus, Norwalk Hospital and Sharon Hospital in Connecticut; Northern Dutchess Hospital, Putnam Hospital and Vassar Brothers Medical Center in New York; and many primary and specialty care practices including The Heart Center — a leading provider of cardiology care — and three urgent care offices. Nuvance Health affiliates offer non-acute care including Home Care and the Thompson House for rehabilitation and skilled nursing services. Visit nuvancehealth.org for more information. TTY: 1-800-421-1220